37 GHP Q3 2024 development in the Americas and Europe,” says Ms. West, “we are clients’ gateway to Asia, with boots on the ground throughout Japan, China, Taiwan, Korea, and Singapore. Our local expertise allows us to help clients navigate the regulatory pathways and clinical development processes in the Asia-Pacific region.” Across many of its projects, clients appreciate the expertise and high quality of service delivery Linical strives for, resulting in a strong base of returning customers. One client, the Chief Medical Officer of a mid-sized biopharmaceutical company, shares, “we love working with Linical across our development programs,” calling the company a “true partner” which “collaborates effectively with our team and aligns with our goals.” Another satisfied client, a Clinical Trial Director, says that without Linical “we could not have made these almost impossible timelines,” praising the team’s “continued support and hard work.” As the industry evolves, Linical deploys innovative tools and remains technologically agnostic, aligning itself seamlessly with clients’ various tech needs and desires. As long as they are appropriately balanced with clients’ timelines and budgetary requirements, Linical embraces both emerging and established technologies to achieve the greatest efficiency and quickest approval times. In order to better the patient journey, the company may recommend customized technological solutions, driving newfound operational efficiency. Ms. West summarizes this by saying, “Linical is committed to embracing technology as it rapidly changes and evolves in our industry. We provide innovative solutions customized to specific indications to help achieve enrollment success and timelines.” The company is currently in the midst of several exciting projects spanning neurology, vaccine development, and oncology. Clients often opt for Linical’s CRO services over larger organizations, demonstrating its unique presence in the market and suitability to partner with worldwide organizations. For quality clinical trials in Asia and beyond, Linical is achieving widespread recognition among the best CRO service providers, and that recognition appears to keep growing. Contact: Ali Cundari, Senior Director Marketing and Corporate Communications Company: Linical Web Address: www.linical.com Email: [email protected] Linical is a mid-sized CRO with the tools to assist clients through early-to-late phase clinical development. From the very beginning of a trial to its end, Linical is poised to help clients position their study for optimal results and adeptly manage operational elements such as identifying investigative sites, enrolling patients, monitoring clinical study data, and beyond. Though it is headquartered in Japan, Linical’s reach extends to all major markets, and clients across each of those markets praise the team’s clinical and business acumen alike. “Our team goes beyond operational excellence, providing flexibility, guidance, and key strategies to successfully overcome drug development and regulatory challenges. We strive to offer professional, highquality services with the personal attention needed in a constantly evolving pharmaceutical and biotech market.” Linical’s focus areas include phase I–IV studies in oncology, neurology and psychiatry services, immunology and vaccine, and endocrinology and metabolic disease CRO services. Its honed focus allows for a tailored approach to suit clients’ specific needs. In Clareece West’s words, “rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and the right team.” Linical’s goal is to be precisely the right partner to support clients through their unique research journeys. The Linical approach is not solely defined by its technical excellence, however. The team’s focus is also on outstanding service underpinned by high-touch methods, prizing regular and transparent communication combined with a shared passion for advancing clients’ promising therapies. Its mid-sized team boasts the benefits of both a smaller and larger CRO, providing agile, personalized service and the global market presence comparable to its large-scale industry peers. Linical’s multi-national client base benefits enormously from this widespread reach. “In addition to supporting innovative drug When seeking a Contract Research Organization (CRO), pharmaceutical and biotech companies need to find just the right fit for their needs. Thanks to its global reach and high-touch approach, clients across a range of clinical development projects attest to the services of Linical, a global CRO with a distinguished presence across Europe, the Americas, and Asia-Pacific. We had the chance to speak with Linical’s President in Europe and the Americas, Clareece West, to celebrate the company’s success. Taking the Legwork out of Your Clinical Trials
RkJQdWJsaXNoZXIy MTUyMDQwMA==